This suggests that SLC34A1 may serve as a valuable diagnostic and prognostic marker for ccRCC, and that SLC34A1 DNA methylation could be linked to the prognosis of ccRCC patients. Here, SLC34A1 is linked to nonpapillary renal cell carcinoma.